Article Versions Notes

Alasmari MS, Alasmari F, Alasmari AF, Alshamsan A, Alsanea S, Rasool MF, Alqahtani F. Development and Evaluation of a Physiologically Based Pharmacokinetic Model for Predicting Haloperidol Exposure in Healthy and Disease Populations. Pharmaceutics. 2022; 14(9):1795. https://doi.org/10.3390/pharmaceutics14091795

Alasmari, Mohammed S., Fawaz Alasmari, Abdullah F. Alasmari, Aws Alshamsan, Sary Alsanea, Muhammad F. Rasool, and Faleh Alqahtani. 2022. "Development and Evaluation of a Physiologically Based Pharmacokinetic Model for Predicting Haloperidol Exposure in Healthy and Disease Populations" Pharmaceutics 14, no. 9: 1795. https://doi.org/10.3390/pharmaceutics14091795

Alasmari, M. S., Alasmari, F., Alasmari, A. F., Alshamsan, A., Alsanea, S., Rasool, M. F., & Alqahtani, F. (2022). Development and Evaluation of a Physiologically Based Pharmacokinetic Model for Predicting Haloperidol Exposure in Healthy and Disease Populations. Pharmaceutics, 14(9), 1795. https://doi.org/10.3390/pharmaceutics14091795